Patents by Inventor Bart Neyns

Bart Neyns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPY AND MEDICAMENT USING INTEGRIN LIGANDS FOR TREATING CANCER
    Publication number: 20110230423
    Abstract: The invention relates to a combination therapy for the treatment of tumors and tumor metastases comprising administration of integrin ligands, preferably integrin antagonists, together with co-therapeutic agents or therapy forms that have synergistic efficacy when administered consecutively with said ligands, such as chemotherapeutic agents and or radiation therapy. The therapy results in a synergistic potential increase of the inhibition effect of each individual therapeutic on tumor cell proliferation, yielding more effective treatment than found by administering an individual component alone, concurrently or not in the dosage regime of the present invention.
    Type: Application
    Filed: November 13, 2009
    Publication date: September 22, 2011
    Inventors: Martin Andreas Picard, Christian Manegolo, Helen Wheeler, Mustafa Khasraw, Bart Neyns
  • Recombinant vectors derived from adeno-associated virus expressing tam67 for gene therapy
    Publication number: 20050175587
    Abstract: The present invention is related to a recombinant adeno associated viral construct comprising at least: a first terminal repeat of an Adeno Associated Virus a strong heterologous promoter an heterologous DNA corresponding to the gene encoding for the c-jun mutant protein TAM67, said gene being under the control of said promoter a polyadenylation signal, and a second terminal repeat of an Adeno Associated Virus
    Type: Application
    Filed: July 26, 2002
    Publication date: August 11, 2005
    Applicant: VRIJE UNIVERSITEIT BRUSSEL
    Inventors: Jacques De Greve, Erik Teugels, Bart Neyns, Ziad Zeinoun, Joanna Vermeij
  • Recombinant vector derived from adeno-associated virus for gene therapy
    Publication number: 20050074886
    Abstract: The present invention is related to a recombinant adeno-associated viral construct comprising at least: a first terminal repeat of an Adeno Associated Virus a strong heterologous promoter an heterologous DNA with at least 90% homology to the gene encoding for a constitutively activated TGF-b1 peptide, said gene being under the control of said promoter a polyadenylation signal a second terminal repeat of an Adeno Associated Virus
    Type: Application
    Filed: July 26, 2002
    Publication date: April 7, 2005
    Inventors: Jacques De Greve, Erik Teugels, Bart Neyns, Ziad Zeinoun, Joanna Vermeij